🎉 Health Canada Provides a No Objection Letter for ATMA’s N500 Phase II Clinical Trial Application

Thank you for your submission!

We've received your request and have sent you an email confirmation.

In the meantime, you may want to check out...


Our blogs explore informative and relevant topics on psychedelic medicine.

News & Media

The latest news and media releases on ATMA and our contributions.

Oregon Psilocybin Services

Learn more on how Oregon’s legal framework is accelerating psilocybin-assisted therapy for practitioners.

Psychedelic Exposé

Our free monthly webinars cover a variety of topics within the psychedelic landscape.